Synmosa Biopharma Corp operates in the Pharmaceutical preparations sector.
In addition to historical fundamental analyses, the complete report available to purchase compares Synmosa Biopharma Corp with three other
companies in this sector in Taiwan:
Formosa Laboratories, Inc
sales of 2.54 billion Taiwanese Dollars [US$86.46 million]
of which 100%
was Active Pharmaceutical Ingredient),
Chi Sheng Pharma & Biotech Co Ltd
(1.04 billion Taiwanese Dollars [US$35.57 million]
Nang Kuang Pharmaceutical Co., Ltd
(1.50 billion Taiwanese Dollars [US$51.20 million]
Synmosa Biopharma Corp reported sales of 1.86 billion Taiwanese Dollars (US$63.37 million)
December of 2017.
decrease of 0.2%
versus 2016, when the company's sales were 1.87 billion Taiwanese Dollars.
Contributing to the drop in overall sales was the 2.2% decline
in Generic Drugs, from 1.83 billion Taiwanese Dollars to 1.79 billion Taiwanese Dollars.
However, these declines were partially offset by the increase in sales of
Material Drugs (up 98.5% to 72.51 million Taiwanese Dollars)